Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: Effects of ibopamine and captopril

Journal of Cardiac Failure

Volumn 3, Issue 2, 1997, Pages 125-132

  Buikema, Hendrik ^a   Van Veldhuisen, Dirk J ^b   Hegeman, Han ^a   Van Gilst, Wiek H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chronic heart failure; Endothelium dependent relaxation; Methacholine

Indexed keywords

CAPTOPRIL; CARDIOTONIC AGENT; DRUG DERIVATIVE; EPININE; IBOPAMINE; NORADRENALIN; VASODILATOR AGENT;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; HEART INFARCTION; HEMODYNAMICS; MALE; PATHOPHYSIOLOGY; RAT; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; CAPTOPRIL; CARDIOTONIC AGENTS; DEOXYEPINEPHRINE; ENDOTHELIUM, VASCULAR; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL INFARCTION; NOREPINEPHRINE; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 0031158966     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90046-4     Document Type: Article

References (37)

1. Teerlink JR, Clozel M, Fischli W, Clozel J-P: Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol 1993;22:615-20.
2. Rafjer SI, Rossen JD, Douglas FL, Goldberg LI, Karrison T: Effect of long-term therapy with oral ibopamine on resting exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels. Circulation 1986;73:740-8.
3. Dei Cas L, Metra M, Visioli O: Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. Am J Cardiol 1992;70:629-34.
4. Van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJM, Lok DJA, Dohmen HJM, Poortermans JC, Withagen AJAM, Pasteuning WH, Brouwer J, Lie KI: Double-blind, placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993;22:1564-73
5. Ferrini R, Miragoli G: Effects of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and α- and β-adrenergic antagonists. Drug Res 1986;36:323-6.
6. Van Veldhuisen DJ, Van Gilst WH, De Smet BJGL, De Graeff PA, Scholtens E, Buikema H, Girbes ARJ, Wesseling H, Lie KI: Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. Cardiovasc Drugs Ther 1994;8:245-50
7. Buikema H, van Gilst WH, van Veldhuisen DJ, de Smet BJGL, Scholtens E, Lie KI, Wesseling H: Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovasc Res 1993;27:2118-24
8. Miller VM, Vanhoutte PM: Enhanced release of endothelium-derived relaxing factor(s) by chronic increases in blood flow. Am J Physiol 1988;255:H446-51
9. Lindsay DC, Jiang C, Brunotte F, Adamopoulos S, Coats AJS, Rajagopalan B, Poole-Wilson PA, Collins P: Impairment of endothelium-dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res 1992;26:694-7
10. Ontkean MT, Gay R, Greenberg B: Effects of chronic captopril therapy on endothelium-derived relaxing factor activity in heart failure. J Am Coll Cardiol 1992;19:207A (abstr)
11. Thuillez C, Mulder P, Elfertak L, Blaysat G, Compagnon, Henry J-P, Richard V, Scalbert E, Desche P: Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Am J Hypertens 1995; 8:7S-12S
12. Van Gilst WH, van Veldhuisen DJ, Hegeman H, Buikema H, Scholtens E, de Graeff PA, Lie KI: Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. J Cardiovasc Pharmacol 1994;24:171-4
13. Hirsch AT, Talsness CE, Smith AD, Schunkert H, Inglefinger JR, Dzau VJ: Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Circulation 1992;86:1566-74
14. Van Wijngaarden J, Pinto YM, van Gilst WH, de Graeff PA, de Langen CDJ, Wesseling H: Converting enzyme inhibition after experimental myocardial infarction in rats: a comparative study between spirapril and zofenopril. Cardiovasc Res 1991;25:939-42
15. Westerink BHC: Analyses of trace amounts of catecholamines and related compounds in brain tissue: a study near the detection limit of liquid chromatography with electrochemical detection. J Chromatogr 1983;6: 2337-51
16. Van Wijngaarden J, Monnink SHJ, Bartels H, van Gilst WH, de Graeff PA, de Langen CDJ, Wesseling H: Captopril modifies the response of infarcted hearts to isoprenaline stimulation. J Cardiovasc Pharmacol 1992;19: 741-7
17. Buikema H, Grandjean JG, van der Broek S, van Gilst WH, Lie KI, Wesseling H: Differences in vasomotor control between human gastroepiploic and left internal mammary artery. Circulation 1992;86(suppl II):205-9
18. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E: Left ventricular diastolic-volume relations in rats with healed myocardial infarction. Circ Res 1981;49:618-26
19. Buikema H, Anthonio RL, Rooks G, van Buiten A, Scholtens E, van Gilst WH: Effects of chronic metoprolol and captopril treatment on endothelium-dependent relaxation in rats with experimental heart failure. Circulation 1996;94(suppl I):I-40 (abstr)
20. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH: Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25
21. Katz SD, Schwarz M, Yuen J, LeJemtel TH: Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 1993; 88:55-61
22. Kaiser L, Spickard RC, Olivier NB: Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-7
23. Melkumyants AM, Balashov SA: Effects of blood viscocity on arterial flow induced dilator response. Cardiovasc Res 1990;24:165-8
24. Pohl U, Busse R, Kuon E, Bassenge E: Pulsatile perfusion stimulates the release of endothelial autocoids. J Appl Cardiol 1986;1:215-35
25. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42
26. DeFelice A, Frering R, Horan P: Time course of hemodynamic changes in rats with healed severe myocardial infarction. Am J Physiol 1989;257:H289-96
27. Bristow MR, Sandoval AB, Gilbert EM, Deisher T, Minobe W, Rasmussen R: Myocardial α- and β-adrenergic receptors in heart failure is cardiac-derived norepinephrine the regulatory signal? Eur Heart J 1988;9(suppl H):35-40
28. Packer M: The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-54
29. Pinto YM, de Smet BGJL, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H: Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovasc Res 1993;27:1933-8
30. Holtz J: Pathophysiology of heart failure and the renin-angiotensin-system. Basic Res Cardiol 1993;88 (suppl 1P):183-201
31. Goetz RM, Studer R, Holtz J: Hypertension-induced enhancement of angiotensin converting enzyme expression in distensible rat arteries: indirect relation to attenuated endothelium-mediated dilation. Eur Heart J 1994;15 (suppl):422 (abstr)
32. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH: The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996;17:787-94
33. Kingma JH, van Gilst WH, Peels CH, Damrink JHE, Verheugt WA, Wielenga RP, CATS Investigators Group: Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction: results from the Captopril and Thrombolysis Study (CATS). Eur Heart J 1994;15:898-907
34. Van Gilst WH, de Graeff PA, Kingma JH, Wesseling H, de Langen CDJ: Captopril reduces purine loss and reperfusion arrythmias in the rat's heart after coronary artery occlusion. Eur J Pharmacol 1984;100:113-17
35. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H: Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89: 2273-82
36. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-72
37. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme activity in experimental heart failure. Circ Res 1991;69:475-82